Asymmetric Dimethyarginine as Marker and Mediator in Ischemic Stroke

Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is known as mediator of endothelial cell dysfunction and atherosclerosis. Circulating ADMA levels are correlated with cardiovascular risk factors such as hypercholesterolemia, arterial hypertension, diabetes mel...

Full description

Bibliographic Details
Main Authors: Karin Weissenborn, Qiang Dong, Jan T. Kielstein, Milani Deb-Chatterji, Na Li, Shufen Chen, Hans Worthmann
Format: Article
Language:English
Published: MDPI AG 2012-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/13/12/15983